Search

Your search keyword '"Rosti, G."' showing total 1,255 results

Search Constraints

Start Over You searched for: Author "Rosti, G." Remove constraint Author: "Rosti, G."
1,255 results on '"Rosti, G."'

Search Results

1. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

4. Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study

6. Differences among young adults, adults and elderly chronic myeloid leukemia patients

7. Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

10. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party

12. S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB VERSUS IMATINIB WITH EARLY SWITCH TO NILOTINIB TO OBTAIN SUSTAINED TREATMENT-FREE REMISSION IN PATIENTS WITH WITH CHRONIC MYELOID LEUKEMIA

13. P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) FROM THE PACE AND OPTIC TRIALS

14. P698: BOSUTINIB DOSE OPTIMIZATION IN THE SECOND-LINE TREATMENT OF ELDERLY CML PATIENTS: EXTENDED 3-YEAR FOLLOW-UP AND FINAL RESULTS OF THE BEST STUDY

15. P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REPORTED SYMPTOMS IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN REAL-LIFE PRACTICE

16. S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILITY AND ENHANCES CLONOGENIC POTENTIAL OF CHRONIC MYELOID LEUKEMIA (CML) PROGENITORS

20. The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview

21. First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation

22. Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

26. Differences among young adults, adults and elderly chronic myeloid leukemia patients

30. Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib

35. Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey

48. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

Catalog

Books, media, physical & digital resources